Literature DB >> 25745995

Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.

F Hu1,2, X Deng1,2, X Yang3, H Jin2, D Gu2,4, X Lv5, C Wang2, Y Zhang2, X Huo2, Q Shen2, Q Luo2, F Zhao2, T Ge1,2, F Zhao2, W Chu2, H Shu2, M Yao2, J Fan3, W Qin2.   

Abstract

Hypoxic microenvironment is a powerful driving force for the invasion and metastasis of hepatocellular carcinoma (HCC). Hypoxia-inducible factor 1α (HIF-1α), as a crucial regulator of transcriptional responses to hypoxia, induces the expression of multiple target genes involved in different steps of HCC metastatic process. It is critical to find target genes associated with metastasis under hypoxia for shedding new light on molecular mechanism of HCC metastasis. In this study, we uncovered that hypoxia could induce the upregulation of Rab11-family interacting protein 4 (Rab11-FIP4) and activation of Rab11-FIP4 promoter by HIF-1α. The overexpression of Rab11-FIP4 significantly enhanced the mobility and invasiveness of HCC cells in vitro, also contributed to distant lung metastasis in vivo, whereas silencing of Rab11-FIP4 decreased the ability of migration and invasion in HCC cells in vitro and suppressed lung metastasis in vivo. Rab11-FIP4 facilitated HCC metastasis through the phosphorylation of PRAS40, which was regulated by mTOR. Furthermore, the expression level of Rab11-FIP4 was significantly increased in HCC tissues and high expression of Rab11-FIP4 was closely correlated with vascular invasion and poor prognosis in HCC patients. A markedly positive correlation between the expression of Rab11-FIP4 and HIF-1α was observed in HCC tissues and combination of Rab11-FIP4 and HIF-1α was a more valuable predictor of poor prognosis for HCC patients. In conclusion, Rab11-FIP4 is a target gene of HIF-1α and has a pro-metastatic role in HCC, suggesting that Rab11-FIP4 may be a promising candidate target for HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25745995     DOI: 10.1038/onc.2015.49

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications.

Authors:  Nazario Portolani; Arianna Coniglio; Sara Ghidoni; Mara Giovanelli; Anna Benetti; Guido Alberto Massimo Tiberio; Stefano Maria Giulini
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

Review 2.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

Review 3.  Activation of the HIF pathway in cancer.

Authors:  P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

4.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

5.  Rab11-FIP4 is predominantly expressed in neural tissues and involved in proliferation as well as in differentiation during zebrafish retinal development.

Authors:  Akihiko Muto; Ken-Ichi Arai; Sumiko Watanabe
Journal:  Dev Biol       Date:  2006-02-02       Impact factor: 3.582

Review 6.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

7.  Rab11 regulates recycling through the pericentriolar recycling endosome.

Authors:  O Ullrich; S Reinsch; S Urbé; M Zerial; R G Parton
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

Review 8.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

Review 9.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

10.  Rab11-FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic in cytokinesis.

Authors:  Andrew B Fielding; Eric Schonteich; Johanne Matheson; Gayle Wilson; Xinzi Yu; Gilles R X Hickson; Sweta Srivastava; Stephen A Baldwin; Rytis Prekeris; Gwyn W Gould
Journal:  EMBO J       Date:  2005-09-08       Impact factor: 11.598

View more
  17 in total

1.  Non-invasive monitoring of the therapeutic response in sorafenib-treated hepatocellular carcinoma based on photoacoustic imaging.

Authors:  Seunghyun Lee; Jung Hoon Kim; Jae Hwan Lee; Jeong Hwa Lee; Joon Koo Han
Journal:  Eur Radiol       Date:  2017-07-27       Impact factor: 5.315

2.  Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.

Authors:  Wu-Gui Chen; Jing Sun; Wei-Wei Shen; Si-Zhen Yang; Ying Zhang; Xu Hu; Hao Qiu; Shang-Cheng Xu; Tong-Wei Chu
Journal:  Clin Exp Metastasis       Date:  2019-01-07       Impact factor: 5.150

3.  Effect of hypoxia inducible factor-1 antisense oligonucleotide on liver cancer.

Authors:  Hongzhang Li; Jiaoe Chen; Wanli Zen; Xuehua Xu; Yanjun Xu; Qiang Chen; Tiangan Yang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.

Authors:  Yang You; Qiongdan Zheng; Yinying Dong; Xiaoying Xie; Yaohui Wang; Sifan Wu; Lan Zhang; Yingcong Wang; Tongchun Xue; Zhiming Wang; Rongxin Chen; Yanhong Wang; Jiefeng Cui; Zhenggang Ren
Journal:  Oncotarget       Date:  2016-05-31

5.  De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.

Authors:  Magdalena Görtz; Uwe Galli; Thomas Longerich; Margot Zöller; Ulrike Erb; Peter Schemmer
Journal:  Oncol Rep       Date:  2017-09-20       Impact factor: 3.906

6.  Downregulation of esophageal cancer-related gene 4 promotes proliferation and migration of hepatocellular carcinoma.

Authors:  Shujian Ge; Yali Xu; Hongliang Wang; Yaxin Sun; Xiangguo Tian; Zhixin Cao; Xiaoyan Lin; Jiawen Xu; Qiangxiu Wang
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 7.  Hypoxia inducible factors in hepatocellular carcinoma.

Authors:  Chu Chen; Tao Lou
Journal:  Oncotarget       Date:  2017-07-11

8.  High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer.

Authors:  Yun He; Mengsi Ye; Lingling Zhou; Yunfeng Shan; Guangrong Lu; Yuhui Zhou; Jinwei Zhong; Jihang Zheng; Zhanxiong Xue; Zhenzhai Cai
Journal:  Int J Oncol       Date:  2016-12-30       Impact factor: 5.650

9.  Extracellular Vesicles from Hypoxic Adipocytes and Obese Subjects Reduce Insulin-Stimulated Glucose Uptake.

Authors:  Justyna Mleczko; Francisco J Ortega; Juan Manuel Falcon-Perez; Martin Wabitsch; Jose Manuel Fernandez-Real; Silvia Mora
Journal:  Mol Nutr Food Res       Date:  2018-02-20       Impact factor: 5.914

Review 10.  PRAS40 signaling in tumor.

Authors:  Dan Lv; Lianying Guo; Ting Zhang; Lin Huang
Journal:  Oncotarget       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.